Case Control Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2208-2223
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2208
Table 1 Patients’ main characteristics

Αdenocarcinoma, n = 56
Colon polyps, n = 33
Controls, n = 81
Age in yr, n (%)
50-591 (1.8)8 (24.2)9 (11.1)
60-6920 (35.7)12 (36.4)44 (54.3)
70-7928 (50.0)11 (33.3)16 (19.8)
80-947 (12.5)2 (6.1)12 (14.8)
Sex
Men35 (62.5)21 (63.6)44 (54.3)
Women21 (37.5)12 (36.4)37 (45.7)
Smoking
Yes50 (89.3)17 (51.5)68 (84.0)
No6 (10.7)16 (48.5)13 (16.0)
Number of cigarettes/d
< 204 ± 8.03 ± 17.60 ± 0.0
2010 ± 20.06 ± 35.320 ± 29.4
> 2036 ± 72.08 ± 47.148 ± 70.6
Smoking duration in yr (mean ± SD)37.7 ± 10.033.5 ± 9.140.3 ± 6.2
Table 2 Distribution (median 25-75 percentile) of antioxidants and oxidants compounds in the plasma by group

Αdenocarcinoma, n = 56
Colon polyps, n = 33
Controls, n = 81
Αntioxidants
Αntioxidant capacity in μmol/L185.0 (177.0-190.0)190.0 (182.0-196.2)305.0 (298.0-324.0)
Vitamin Α in μg/L391.5 (288.3-493.8)572.0 (480.0-609.0)380.0 (350.0-416.0)
Vitamin C in μg/L4.7 (3.9-6.5)6.0 (4.7-10.0)6.0 (4.5-9.0)
Vitamin E in mg/L3.5 (2.4-3.9)3.8 (3.5-4.2)3.7 (3.2-4.0)
Vitamin D in ng/mL9.0 (6.7-13.0)9.0 (6.8-20.5)24.0 (20.0-26.0)
Se in μg/L62.0 (45.5-78.8)78.0 (72.0-80.0)76.0 (69.5-80.0)
Zn in μg/L626.5 (594.5-782.5)800.0 (711.0-840.0)809.0 (780.5-842.5)
B12 in pg/L211.0 (159.3-297.0)250.0 (220.0-355.0)289.0 (200.0-340.0)
Folic acid in ng/L4.3 (3.3-4.6)4.2 (3.9-4.6)4.0 (3.8-4.4)
Οxidants
Οxidant activity in μmol/L368.8 (330.8-409.0)378.0 (348.5-409.1)172.0.0 (167.5-178.5)
Μalondialdehyde in μmol/L)1.9 (1.6-2.4)1.2 (0.9-2.0)1.8 (1.7-1.9)
Fe2+ in μg/dL)64.0 (49.3-92.3)110.0 (90.0-127.0)68.0 (51.0-95.0)
Table 3 Percent change (and 95%CIs respectively) in the levels of serum antioxidant and oxidant substances compared to the control group
Colon polyps
Colon adenocarcinoma
% Change (95%CI)
% Change (95%CI)
Antioxidants
Antioxidant capacity -40.1 (-41.6 to -38.5)-40.7 (-41.8 to -39.5)
Vitamin Α 32.2 (20.8 to 44.7)0.1 (-6.9 to 7.6)
Vitamin C -3.1 (-15.8 to 11.6)-12.7 (-21.9 to -2.4)
Vitamin E 4.2 (-5.0 to 14.2)-12.3 (-18.4 to -5.7)
Vitamin D -46.0 (-54.9 to -35.4)-56.8 (-62.6 to -50.2)
Se 1.7 (-6.3 to 10.4)-19.4 (-24.5 to -14.0)
Zn -6.7 (-12.9 to 0.0)-20.2 (-24.5 to -15.7)
B12 6.0 (-11.7 to 27.2)-15.0 (-26.5 to -1.8)
Folic acid 2.1 (-6.9 to 12.0)-8.2 (-14.7 to -1.3)
Oxidants
Oxidant activity 120.1 (111.7 to 128.9)113.4 (106.8 to 120.2)
Malondialdehyde-31.6 (-39.8 to -22.3)10.1 (-0.6 to 21.9)
Fe2+43.5 (22.2 to 68.5)-8.9 (-19.8 to 3.5)
Table 4 Results from multiple logistic regression models (odds ratios and 95%CIs) for the risk of colon adenocarcinoma in comparison to the control group1

Odds ratio
95%CI
P value
Antioxidants
Vitamin Α, per 99.6 μg/L1.200.77-1.880.430
Vitamin C, per 2.8 μg/L0.710.44-1.150.168
Vitamin E, per 0.7 mg/L0.570.39-0.840.004
Vitamin D, per 8.2 ng/mL0.040.02-0.12< 0.001
Se, per 13.6 μg/L0.350.22-0.55< 0.001
Zn, per 128.5 μg/L0.160.09-0.31< 0.001
B12, per 157.1 pg/L0.800.51-1.260.337
Folic acid, per 38.1 ng/L0.770.54-1.110.170
Oxidants
Malondialdehyde, per 0.5 μmol/L2.091.27-3.450.004
Fe2+, per 33.9 μg/dL0.730.47-1.130.154
Table 5 Multiple logistic regression results (odds ratios and 95%CIs) for the risk of colon polyp development in comparison to the control group1

Odds ratio
95%CI
P value
Antioxidants
Vitamin Α, per 99.6 μg/L8.843.76-20.74< 0.001
Vitamin C, per 2.8 μg/L0.990.58-1.700.982
Vitamin E, per 0.7 mg/L1.510.87-2.630.141
Vitamin D, per 8.2 ng/mL0.270.15-0.48< 0.001
Se, per 13.6 μg/L1.680.82-3.420.157
Zn, per 128.5 μg/L0.390.16-0.940.036
B12, per 157.1 pg/L1.510.92-2.460.103
Folic acid, per 38.1 ng/L1.420.74-2.720.299
Οxidants
Malondialdehyde, per 0.5 μmol/L0.350.20-0.60< 0.001
Fe2+, per 33.9 μg/dL2.581.53-4.33< 0.001